TMED6
Transmembrane emp24 domain-containing protein 6
Also known as: MGC23911, p24g5, p24gamma5, TMED6_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8WW62
- Gene
- TMED6
- Ensembl
- ENSG00000157315
- Chromosome
- 16
- Canonical length
- 240 aa
- Protein class
- Predicted membrane proteins
OverviewNCBI Gene
Predicted to be involved in Golgi organization; endoplasmic reticulum to Golgi vesicle-mediated transport; and intracellular protein transport. Predicted to be located in endoplasmic reticulum membrane. Predicted to be active in several cellular components, including COPII-coated ER to Golgi transport vesicle; Golgi apparatus; and endoplasmic reticulum-Golgi intermediate compartment. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
240 residues, UniProt reviewed canonical sequence.
>Q8WW62|TMED6
1 MSPLLFGAGL VVLNLVTSAR SQKTEPLSGS GDQPLFRGAD RYDFAIMIPP GGTECFWQFA
61 HQTGYFYFSY EVQRTVGMSH DRHVAATAHN PQGFLIDTSQ GVRGQINFST QETGFYQLCL
121 SNQHNHFGSV QVYLNFGVFY EGPETDHKQK ERKQLNDTLD AIEDGTQKVQ NNIFHMWRYY
181 NFARMRKMAD FFLIQSNYNY VNWWSTAQSL VIILSGILQL YFLKRLFNVP TTTDTKKPRCLocalizationUniProt · AlphaFold · HPA
Whether an antibody against TMED6 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.41
- Highest tissue expression
- 282 nTPM
Expression across tissuesHPA
Tissue
- pancreas: 282 nTPM
- stomach: 60 nTPM
- fallopian tube: 21 nTPM
- epididymis: 17 nTPM
- kidney: 15 nTPM
- duodenum: 12 nTPM
Single-cell type
- gastric chief cells: 237 nCPM
- parietal cells: 90 nCPM
- fallopian tube ciliated cells: 10 nCPM
- endometrial ciliated cells: 7.9 nCPM
- mucous neck cells: 6.3 nCPM
- neuroendocrine cells: 5.1 nCPM
Immune cell
- memory CD4 T-cell: 0.4 nTPM
- naive CD8 T-cell: 0.3 nTPM
- MAIT T-cell: 0.2 nTPM
- gdT-cell: 0.1 nTPM
- intermediate monocyte: 0.1 nTPM
- memory B-cell: 0.1 nTPM
Brain region
- cerebellum: 3.7 nTPM
- cerebral cortex: 3.2 nTPM
- white matter: 2.8 nTPM
- hippocampal formation: 2.7 nTPM
- basal ganglia: 2.5 nTPM
- thalamus: 2.4 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.16
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.52
- DepMap mean gene effect
- -0.1
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- endoplasmic reticulum to Golgi vesicle-mediated transport
- Golgi organization
- intracellular protein transport
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TMED6 as an antibody target. Whether an autoantibody or antibody against TMED6 could matter depends on whether native TMED6 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TMED6 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label TMED6 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...